Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
This is a prospective, observational study to collect stool and blood from acute myeloid leukemia patients undergoing intensive chemotherapy.
Acute Myeloid Leukemia
DIAGNOSTIC_TEST: Sample Collection Blood|DIAGNOSTIC_TEST: Stool Sample
Abundance of Phyla, Abundance in stool and circulating microbiota during intensive chemotherapy in patients with acute myeloid leukemia (AML), measured by16S rRNA gene profiling of biospecimens using the Illumina MiSeq platform, Day 28|Abundance of Genera, Abundance in stool and circulating microbiota during intensive chemotherapy in patients with acute myeloid leukemia (AML), measured by16S rRNA gene profiling of biospecimens using the Illumina MiSeq platform, Day 28
Circulating Microbiota Diversity (Blood), Describe circulating microbiota diversity over the course of treatment, Day 28|Microbiota Diversity (Stool), Describe stool microbiota diversity over the course of treatment, Day 28
This is a prospective, observational study to collect stool and blood from acute myeloid leukemia patients undergoing intensive chemotherapy.